Skip to menu Skip to content Skip to footer

2023

Journal Article

An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models

Dixit, Aakanksha, Savage, Hannah S. and Greer, Judith M. (2023). An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models. Expert Opinion on Therapeutic Targets, 27 (7), 553-574. doi: 10.1080/14728222.2023.2236301

An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models

2017

Journal Article

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms

Dixit, Aakanksha, Tanaka, Akane, Greer, Judith M and Donnelly, Sheila (2017). Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. International Journal of Molecular Sciences, 18 (10) 2141, 1-17. doi: 10.3390/ijms18102141

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms

2016

Journal Article

A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis

Lund, Maria E., Greer, Judith M., Dixit, Aakanksha, Alvarado, Raquel, McCauley-Winter, Padraig, To, Joyce, Tanaka, Akane, Hutchinson, Andrew T., Robinson, Mark W., Simpson, Ann M., O'Brien, Bronwyn A., Dalton, John P. and Donnelly, Sheila (2016). A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Scientific Reports, 6 (1) 37789, 37789. doi: 10.1038/srep37789

A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis

2013

Journal Article

Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis

Ji, Niannian, Somanaboeina, Animesh, Dixit, Aakanksha, Kawamura, Kazuyuki, Hayward, Neil J., Self, Christopher, Olson, Gary L. and Forsthuber, Thomas G. (2013). Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. Journal of Immunology, 191 (10), 5074-5084. doi: 10.4049/jimmunol.1300407

Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis

2011

Journal Article

Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift

Cantor, Jason R., Yoo, Tae Hyeon, Dixit, Aakanksha, Iverson, Brent L., Forsthuber, Thomas G. and Georgiou, George (2011). Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proceedings of the National Academy of Sciences of the United States of America, 108 (4), 1272-1277. doi: 10.1073/pnas.1014739108

Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift